A UW-Madison scientist says “exciting” new research could pave the way for slowing or even stopping the onset of Alzheimers. Director of Alzheimer’s Research Dr. Sanjay Asthana says researchers are conducting studies with an experimental drug designed to stop amyloid protein from developing in the brain. Abnormal development of the protein has been linked to the disease’s progression.
Office of Strategic Communication